(Q93256488)
Statements
No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy (English)
A Carugno
F Raponi
A G Locatelli
P Vezzoli
D M Gambini
M Di Mercurio
E Robustelli Test